Page 30 - Statement Regarding News Today

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Revenue increased 9% to $11.7 million for the period ended March 31, 2023 (“Q4 FY2023”) versus $10.7 million for the period ended March 31, 2022 Net...

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2023) - Hertz Lithium Inc. (CSE: HZ) (FSE: QE2) (the "Company") announces that it has filed amended and restated condensed interim financial statements

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2023) - Hertz Lithium Inc. (CSE: HZ) (OTC Pink: HZLIF) (FSE: QE2) (the "Company"), a Company focused on lithium exploration and novel extraction

Rare Earth Metal Stock Defense Metals (TSX-V: $DEFN.V) (OTCQB: $DFMTF) Reports Completion of Hydrometallurgical Pilot Plant Testing and Initiates Pre-feasibility Study Design Work

Company Confirms Multiple Pegmatite Drill Core Intercepts at its Knockeen Prospect; Begins Shipping Samples to Lab Vancouver, British Columbia--(Newsfile Corp. - June 7, 2023) - Global Battery Metals

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2023) - Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) ("Hillcrest" or the "Company"), announces an update to the terms of

EQS-News: Defence Therapeutics Inc. / Key word: Miscellaneous Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER 06.06.2023 / 08:00... | June 6, 2023

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER 06.06.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement.